Robert Martell - 20 Jan 2023 Form 4 Insider Report for CURIS INC (CRIS)

Reporting relationship: Head of Research & Development
Issuer ticker: CRIS
Reported as of: 20 Jan 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Jan 2023, 15:09:17 UTC
Prior SEC filing: 31 Jan 2022
Next SEC filing: 14 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Diantha Duvall, Attorney-in-fact

Key filing fact

Robert Martell filed Form 4 for CURIS INC (CRIS) on 24 Jan 2023.

Key facts

This page summarizes Robert Martell's Form 4 filing for CURIS INC (CRIS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Jan 2023, 15:09.

Change

Previous filing in this sequence was filed on 31 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CRIS transaction Derivative

Employee stock option (right to buy)

Award

Transaction value: $0
Shares: +350,000
Change %
Price: $0.000000
Shares after: 350,000
Date: 20 Jan 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 350,000
Exercise price: $0.7000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The option grant described in this Form 4 filing vests as to 25% of the original shares on January 20, 2024 and as to an additional 6.25% of the original shares each successive quarter and until January 20, 2027.

SEC remarks

Exhibit Index: 24.1 Power of Attorney